Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.
Baldwin
A S
AS
Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599, USA.
D000818:Animals; D017209:Apoptosis; D002455:Cell Division; D004351:Drug Resistance; D005786:Gene Expression Regulation; D006801:Humans; D020672:I-kappa B Proteins; D018799:Intercellular Adhesion Molecule-1 / Q000378:metabolism; D016328:NF-kappa B / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000502:physiology*; D009369:Neoplasms / Q000209:etiology* / Q000517:prevention & control; D010766:Phosphorylation; D011518:Proto-Oncogene Proteins / Q000502:physiology*
D020672:I-kappa B Proteins; D016328:NF-kappa B; C105627:NFKBIE protein, human; D011518:Proto-Oncogene Proteins; D018799:Intercellular Adhesion Molecule-1